| P50 | author | Mahlon DeLong | Q15374218 |
| P2093 | author name string | Thomas Wichmann | |
| | Jose A Obeso | |
| | Jorge Guridi | |
| P2860 | cites work | Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease | Q48548811 |
| | Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate | Q48810107 |
| | Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis | Q48898151 |
| | Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | Q49138365 |
| | Evidence in favor of Braak staging of Parkinson's disease. | Q53409292 |
| | Dorsal subthalamotomy for Parkinson's disease. | Q53896853 |
| | Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease | Q57089269 |
| | Degeneration of the centré median-parafascicular complex in Parkinson's disease | Q59544666 |
| | Changes in the local cerebral metabolic rate for glucose in the MPTP primate model of Parkinson's disease | Q68815933 |
| | Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age | Q69262673 |
| | Bilateral subthalamic nucleus stimulation for severe Parkinson's disease | Q70875241 |
| | Organization of nonprimary motor cortical inputs on pyramidal and nonpyramidal tract neurons of primary motor cortex: An electrophysiological study in the macaque monkey | Q73365202 |
| | Basal ganglia and cerebellar loops: motor and cognitive circuits | Q73553166 |
| | Equilibrium potential of GABA(A) current and implications for rebound burst firing in rat subthalamic neurons in vitro | Q73776433 |
| | Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurone in vitro | Q74257952 |
| | Kinematic evaluation of gestural and repetitive single joint movements of the arm after posteroventral pallidotomy, subthalamotomy or both procedures combined in two Parkinson's disease patients: two case studies | Q80915129 |
| | Critical evaluation of the Braak staging scheme for Parkinson's disease | Q84147549 |
| | Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis | Q22242250 |
| | Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 |
| | Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus | Q28241545 |
| | Chronic parkinsonism secondary to intravenous injection of meperidine analogues | Q28323857 |
| | Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease | Q28324320 |
| | Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 |
| | D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 |
| | The functional anatomy of basal ganglia disorders | Q29617461 |
| | Primate models of movement disorders of basal ganglia origin | Q29618489 |
| | Functional architecture of basal ganglia circuits: neural substrates of parallel processing | Q29618729 |
| | Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. | Q31826825 |
| | Evidence of a breakdown of corticostriatal connections in Parkinson's disease. | Q33214147 |
| | Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats. | Q33240647 |
| | Differential excitability and modulation of striatal medium spiny neuron dendrites | Q33382961 |
| | Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial | Q33623861 |
| | High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor | Q33920933 |
| | Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease | Q34049606 |
| | Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys | Q34061020 |
| | Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors | Q34093012 |
| | Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. | Q34144961 |
| | Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system | Q34248307 |
| | The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia | Q34251567 |
| | Extrastriatal dopaminergic circuits of the Basal Ganglia | Q34330022 |
| | Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study | Q34396153 |
| | Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 |
| | Circuits and circuit disorders of the basal ganglia | Q34599488 |
| | Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway | Q34688620 |
| | Pathophysiology of parkinsonism | Q34777496 |
| | Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. | Q42521926 |
| | Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates | Q42526111 |
| | Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease | Q42830127 |
| | What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson's disease. | Q43278477 |
| | Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months | Q43704582 |
| | Movement-related changes in synchronization in the human basal ganglia | Q44002200 |
| | Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake | Q44196091 |
| | Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs | Q44758741 |
| | Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey | Q44987956 |
| | Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. | Q45249855 |
| | Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations | Q45302799 |
| | A neostriatal habit learning system in humans. | Q45979314 |
| | Globus pallidus neurons dynamically regulate the activity pattern of subthalamic nucleus neurons through the frequency-dependent activation of postsynaptic GABAA and GABAB receptors. | Q46586668 |
| | Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex | Q46617667 |
| | Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 |
| | Electrophysiology of globus pallidus neurons in vitro | Q47924524 |
| | Motor subcircuits mediating the control of movement velocity: a PET study | Q48376274 |
| | Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. | Q48391594 |
| | Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease | Q48427735 |
| | Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease | Q48435808 |
| | Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. | Q48454428 |
| | Common neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography | Q48469047 |
| | Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus | Q48482417 |
| | Seven problems on the basal ganglia | Q34903682 |
| | Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). | Q35045422 |
| | Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Q35072636 |
| | Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease | Q35097464 |
| | Macro-architecture of basal ganglia loops with the cerebral cortex: use of rabies virus to reveal multisynaptic circuits | Q35599353 |
| | Dichotomous anatomical properties of adult striatal medium spiny neurons | Q35607269 |
| | Oscillations in the basal ganglia under normal conditions and in movement disorders | Q36531778 |
| | Disinhibition as a basic process in the expression of striatal functions | Q36586037 |
| | Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology | Q36610366 |
| | Basal ganglia oscillations and pathophysiology of movement disorders | Q36644641 |
| | GABAergic control of the subthalamic nucleus | Q36820596 |
| | Pathological synchronization in Parkinson's disease: networks, models and treatments | Q36833065 |
| | Paradoxes of functional neurosurgery: clues from basal ganglia recordings | Q36999845 |
| | Abnormal oscillatory synchronisation in the motor system leads to impaired movement. | Q37067771 |
| | Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys | Q37186952 |
| | A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q37343442 |
| | A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment | Q37585084 |
| | A timeline for Parkinson's disease | Q37619101 |
| | Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up | Q39216879 |
| | Striatal inhomogeneities and basal ganglia function | Q39290893 |
| | Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey | Q39523670 |
| | Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease | Q39732881 |
| | Biochemical and pharmacological aspects of Parkinsonism | Q39898079 |
| | Drug Therapy of Parkinsonism | Q39915162 |
| | The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease | Q40630408 |
| | Basal ganglia intrinsic circuits and their role in behavior | Q40722775 |
| | MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. | Q40817289 |
| | Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding | Q41105661 |
| | Reversal of experimental parkinsonism by lesions of the subthalamic nucleus | Q41241320 |
| | Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea | Q41400116 |
| | Basal ganglia pathophysiology. A critical review. | Q41624512 |
| | Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates | Q41701358 |
| | A critical evaluation of the Braak staging scheme for Parkinson's disease. | Q42260364 |
| | Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism | Q42464540 |
| | Multiple Output Channels in the Basal Ganglia | Q42482773 |
| | Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey | Q42484815 |
| | Neuronal firing before and after burst discharges in the monkey basal ganglia is predictably patterned in the normal state and altered in parkinsonism | Q42488325 |
| | Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey | Q42490761 |
| | The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism | Q42493851 |
| | The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism | Q42493857 |
| | Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. | Q42495652 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. | Q42519040 |
| | Where does parkinson disease pathology begin in the brain? | Q42521711 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathophysiology | Q1135939 |
| | Parkinson's disease | Q11085 |
| P304 | page(s) | 1032-1041 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Milestones in research on the pathophysiology of Parkinson's disease | |
| P478 | volume | 26 | |